Seattle Genetics Reports First Quarter 2014 Financial Results

'Our financial and business results to date in 2014 reflect continued progress across our top three corporate priorities of building ADCETRIS into a major global brand, advancing our robust ADC pipeline and enhancing our leadership position in the field of ADCs,' said Clay B. Siegall, Ph.D., President and Chief Executive Officer at .

http://ift.tt/1ub3MFW